Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia (2024)
Source: European Journal of Pharmacology. Unidades: FM, ICB
Subjects: FARMACOLOGIA, IMUNOLOGIA, ANTINEOPLÁSICOS, SOBREVIVÊNCIA CELULAR, INIBIDORES DE ENZIMAS, PROTEÍNAS QUINASES, PROTEÍNAS PROTO-ONCOGÊNICAS, NEOPLASIAS POR TIPO HISTOLÓGICO, LEUCEMIA
ABNT
LIMA, Keli Cristina de et al. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. European Journal of Pharmacology, v. 977, p. 11 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2024.176723. Acesso em: 18 nov. 2024.APA
Lima, K. C. de, Nogueira, F. L., Cipelli, M., Carvalho, M. F. L., Martins, D. A. P., Silva, W. F. da, et al. (2024). Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. European Journal of Pharmacology, 977, 11 . doi:10.1016/j.ejphar.2024.176723NLM
Lima KC de, Nogueira FL, Cipelli M, Carvalho MFL, Martins DAP, Silva WF da, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Camara NOS, Schuringa JJ, Machado Neto JA, Rego EM. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. European Journal of Pharmacology. 2024 ; 977 11 .[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejphar.2024.176723Vancouver
Lima KC de, Nogueira FL, Cipelli M, Carvalho MFL, Martins DAP, Silva WF da, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Camara NOS, Schuringa JJ, Machado Neto JA, Rego EM. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. European Journal of Pharmacology. 2024 ; 977 11 .[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejphar.2024.176723